Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gwynn Long"'
Autor:
Sendhilnathan Ramalingam, Sharareh Siamakpour-Reihani, Lauren Bohannan, Yi Ren, Alexander Sibley, Jeff Sheng, Li Ma, Andrew B Nixon, Jing Lyu, Daniel C Parker, James Bain, Michael Muehlbauer, Olga Ilkayeva, Virginia Byers Kraus, Janet L Huebner, Thomas Spitzer, Jami Brown, Jonathan U Peled, Marcel van den Brink, Antonio Gomes, Taewoong Choi, Cristina Gasparetto, Mitchell Horwitz, Gwynn Long, Richard Lopez, David Rizzieri, Stefanie Sarantopoulos, Nelson Chao, Anthony D Sung
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252995 (2021)
BackgroundAllogeneic hematopoietic stem cell transplantation (HCT) is an often curative intent treatment, however it is associated with significant gastrointestinal (GI) toxicity and treatment related mortality. Graft-versus-host disease is a signifi
Externí odkaz:
https://doaj.org/article/f83a9f8874344c358e65b574f37f7011
Autor:
Michael M. B. Green, Nelson Chao, Saurabh Chhabra, Kelly Corbet, Cristina Gasparetto, Ari Horwitz, Zhiguo Li, Jagadish Kummetha Venkata, Gwynn Long, Alice Mims, David Rizzieri, Stefanie Sarantopoulos, Robert Stuart, Anthony D. Sung, Keith M. Sullivan, Luciano Costa, Mitchell Horwitz, Yubin Kang
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-10 (2016)
Abstract Background The binding of CXCR4 with its ligand (stromal-derived factor-1) maintains hematopoietic stem/progenitor cells (HSPCs) in a quiescent state. We hypothesized that blocking CXCR4/SDF-1 interaction after hematopoietic stem cell transp
Externí odkaz:
https://doaj.org/article/8c773201044c41c09ecb20b399fbcb3c
Autor:
Emmanuel Katsanis, Therese Hennig, Jacob E. Robinson, Gwynn Long, Nelson Chao, Mitchell Horwitz, David Rizzieri
Publikováno v:
Bone Marrow Transplantation. 57:1845-1847
Autor:
Yubin Kang, Pasupathi Sundaramoorthy, Cristina Gasparetto, Daniel Feinberg, Shengjun Fan, Gwynn Long, Emily Sellars, Anderson Garrett, Sascha A. Tuchman, Brandi N. Reeves, Zhiguo Li, Bei Liu, Besim Ogretmen, Lynn Maines, Vered Katz Ben-Yair, Charles Smith, Terry Plasse
Publikováno v:
Annals of hematologyReferences.
Multiple myeloma (MM) remains an incurable disease and there is an unmet medical need for novel therapeutic drugs that do not share similar mechanisms of action with currently available agents. Sphingosine kinase 2 (SK2) is an innovative molecular ta
Autor:
Patrick J, Smith, Meagan, Lew, Yen, Lowder, Kristi, Romero, Jillian C, Thompson, Lauren, Bohannon, Alyssa, Pittman, Alexandra, Artica, Sendhilnathan, Ramalingam, Taewoong, Choi, Cristina, Gasparetto, Mitchell, Horwitz, Gwynn, Long, Richard, Lopez, David, Rizzieri, Stefanie, Sarantopoulos, Keith, Sullivan, Nelson, Chao, Anthony D, Sung
Publikováno v:
Bone marrow transplantation. 57(1)
Hematopoietic cell transplant (HCT) is an increasingly common and curative treatment strategy to improve survival among individuals with malignant and nonmalignant diseases, with over one million HCTs having been performed worldwide. Neurocognitive d
Autor:
Sascha A, Tuchman, Wendi A, Bacon, Li-Wen, Huang, Gwynn, Long, David, Rizzieri, Mitchell, Horwitz, John P, Chute, Keith, Sullivan, Ashley, Morris Engemann, Amanda, Yopp, Zhiguo, Li, Kelly, Corbet, Nelson, Chao, Cristina, Gasparetto
Publikováno v:
Journal of clinical apheresis. 30(3)
High-dose cyclophosphamide (Cy) is frequently employed for peripheral blood mobilization of hematopoietic stem cells before high-dose chemotherapy with autologous stem cell transplantation (ASCT) in multiple myeloma (MM). The benefit of mobilization